Literature DB >> 18525289

The prevalence of misidentification syndromes in neurodegenerative diseases.

Michal Harciarek1, Andrew Kertesz.   

Abstract

Although misidentification syndromes (MISs) have been often described in Alzheimer disease (AD), the prevalence of these phenomena in different neurodegenerative diseases has not been systematically studied. Three hundred ninety-two individuals with probable AD, 119 patients with the behavioral variety of frontotemporal dementia (FTD-bv), 101 patients with primary progressive aphasia, 24 subjects with semantic dementia, 18 subjects with corticobasal degeneration, 8 patients with progressive supranuclear palsy, 36 individuals with probable Lewy body dementia (DLB), and 26 subjects with Parkinson disease (PD) were the participants of this study. On the basis of a semistructured interview with both patients and their reliable caregivers, MIS was identified in 15.8% of cases with AD, 16.6% of patients with DLB, and in 8.3% of individuals with semantic dementia. The most frequent form of MIS was Capgras delusions, often accompanied by reduplication of place, phantom border phenomenon, or both. Although MIS typically appears in later stages of the disease, it can also occur surprisingly early in patients with AD. None of the patients with FTD-bv, primary progressive aphasia, corticobasal degeneration/supranuclear palsy, or PD developed MIS. Thus, our findings suggest that MISs are characteristic of AD and DLB, and tend to exclude FTD/Pick complex and PD.

Entities:  

Mesh:

Year:  2008        PMID: 18525289     DOI: 10.1097/WAD.0b013e3181641341

Source DB:  PubMed          Journal:  Alzheimer Dis Assoc Disord        ISSN: 0893-0341            Impact factor:   2.703


  17 in total

1.  Neuropsychiatric symptoms in primary progressive aphasia: phenomenology, pathophysiology, and approach to assessment and treatment.

Authors:  Mandana Modirrousta; Bruce H Price; Bradford C Dickerson
Journal:  Neurodegener Dis Manag       Date:  2013-04-01

Review 2.  Psychotic symptoms in frontotemporal dementia.

Authors:  Devin Hall; Elizabeth C Finger
Journal:  Curr Neurol Neurosci Rep       Date:  2015-07       Impact factor: 5.081

Review 3.  Psychiatric issues in cognitive impairment.

Authors:  Dag Aarsland; John-Paul Taylor; Daniel Weintraub
Journal:  Mov Disord       Date:  2014-04-15       Impact factor: 10.338

4.  Cotard syndrome in semantic dementia.

Authors:  Mario F Mendez; Jesús Ramírez-Bermúdez
Journal:  Psychosomatics       Date:  2011 Nov-Dec       Impact factor: 2.386

Review 5.  Capgras syndrome in Parkinson's disease: two new cases and literature review.

Authors:  Antonino Cannas; Mario Meloni; Marcello Mario Mascia; Paolo Solla; Luigi Cocco; Antonella Muroni; Gianluca Floris; Francesca Di Stefano; Francesco Marrosu
Journal:  Neurol Sci       Date:  2016-11-15       Impact factor: 3.307

Review 6.  Neurobiology of delusions in Alzheimer's disease.

Authors:  Zahinoor Ismail; Minh-Quan Nguyen; Corinne E Fischer; Tom A Schweizer; Benoit H Mulsant; David Mamo
Journal:  Curr Psychiatry Rep       Date:  2011-06       Impact factor: 5.285

7.  Capgras syndrome in Dementia with Lewy Bodies.

Authors:  Papan Thaipisuttikul; Iryna Lobach; Yael Zweig; Ashita Gurnani; James E Galvin
Journal:  Int Psychogeriatr       Date:  2012-12-05       Impact factor: 3.878

8.  Capgras' syndrome in first-episode psychotic disorders.

Authors:  Paola Salvatore; Chaya Bhuvaneswar; Mauricio Tohen; Hari-Mandir K Khalsa; Carlo Maggini; Ross J Baldessarini
Journal:  Psychopathology       Date:  2014-02-07       Impact factor: 1.944

9.  Psychosis in neurodegenerative disease: differential patterns of hallucination and delusion symptoms.

Authors:  Georges Naasan; Suzanne M Shdo; Estrella Morenas Rodriguez; Salvatore Spina; Lea Grinberg; Lucia Lopez; Anna Karydas; William W Seeley; Bruce L Miller; Katherine P Rankin
Journal:  Brain       Date:  2021-04-12       Impact factor: 15.255

10.  The effect of PN-1, a Traditional Chinese Prescription, on the Learning and Memory in a Transgenic Mouse Model of Alzheimer's Disease.

Authors:  Zhi-Gang Yao; Ling Zhang; Liang Liang; Yu Liu; Ya-Jun Yang; Lan Huang; Hua Zhu; Chun-Mei Ma; Chuan Qin
Journal:  Evid Based Complement Alternat Med       Date:  2013-02-17       Impact factor: 2.629

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.